CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation
Il Han Kim
Radiation Oncology Journal. 2019;37(1):1-12.   Published online 2019 March 31    DOI: https://doi.org/10.3857/roj.2019.00171

Excel Download

Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation
Il Han Kim
Radiation Oncology Journal. 2019;37(1):1-12   Crossref logo
Link1 Link2 Link3
8703 Clinical effect of hypo-fractionated high-dose irradiation on local control of glioblastoma owing to the status of MGMT promotor methylation
T. Iuchi, K. Hatano, H. Kageyama, T. Sakaida, K. Kawasaki, A. Nakagawara
European Journal of Cancer Supplements. 2009;7(2):494   Crossref logo
Link1 Link2
ACTR-05. PROCARBAZINE AND CCNU CHEMOTHERAPY FOR RECURRENT GLIOBLASTOMA WITH MGMT PROMOTER METHYLATION
Yong Kil Hong, Seung Ho Yang
Neuro-Oncology. 2019;21(Supplement_6):vi13-vi13   Crossref logo
Link1 Link2
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma
Zhengqiu Zhou, Tracy A. Howard, John L. Villano
Cancer Chemotherapy and Pharmacology. 2017;80(5):1043-1046   Crossref logo
Link1 Link2 Link3
Age-Dependent Impact of Concomitant Radio-Chemotherapy and MGMT Promotor Methylation on PFS and OS in Patients with IDH Wild-Type Glioblastoma: The Real-Life Data
Aleksandrs Krigers, Julia Klingenschmid, Tolga Cosar, Patrizia Moser, Claudius Thomé, Christian F. Freyschlag
Cancers. 2022;14(24):6180   Crossref logo
Link1
Quantitative analysis of MGMT promoter methylation status changes by pyrosequencing in recurrent glioblastoma
Víctor González Jiménez, Marta Brell Doval, Cristina Gómez Bellvert, Javier Ibáñez Domínguez, Víctor Goliney, Osman Salazar Asencio, Adriana Gómez Martín
. 2022;   Crossref logo
Link1 Link2
PATH-04. INFLUENCE OF INDIVIDUAL CpG METHYLATION STATUS OF THE MGMT PROMOTOR ON OUTCOME IN ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME RECEIVING ALKYLATING AGENT TREATMENT
Sebastian Siller, Michael Lauseker, Armin Giese, Joerg-Christian Tonn, Karim-Maximilian Niyazi, Niklas Thon, Bogdana Suchorska, Friedrich-Wilhelm Kreth
Neuro-Oncology. 2019;21(Supplement_6):vi143-vi143   Crossref logo
Link1 Link2
PATH-32. EXTENT, PATTERN, AND PROGNOSTIC VALUE OF MGMT PROMOTOR METHYLATION: DOES IT DIFFER BETWEEN GLIOBLASTOMA AND IDH-WILDTYPE/TERT-MUTATED ASTROCYTOMA?
Nico Teske, Philipp Karschnia, Jonathan Weller, Sebastian Siller, Mario M Dorostkar, Jochen Herms, Louisa von Baumgarten, Jörg-Christian Tonn, Niklas Thon
Neuro-Oncology. 2021;23(Supplement_6):vi122-vi122   Crossref logo
Link1 Link2
LARGE VOLUME RE-IRRADIATION IS A VIABLE OPTION IN PATIENTS WITH RECURRENT REFRACTORY GLIOBLASTOMA
Michael Back, Joseph Chan, Dasantha Jayamanne
Neuro-Oncology. 2018;20(suppl_5):v353-v353   Crossref logo
Link1
Bevacizumab combined with re-irradiation in recurrent glioblastoma
Lei She, Lin Su, Chao Liu
Frontiers in Oncology. 2022;12:   Crossref logo
Link1
This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.